Commons Clinic is preempting complex conditions.
The latest: The vertically integrated specialty clinic raised $26M in Series B funding to launch Wholebody, a program combining advanced diagnostics with expert care across cardiometabolic, women’s health, GI, chronic pain, oncology, and more.
Seamless care. Designed to quantify health risks, Wholebody provides a structured path from detection to treatment, including up to three specialist consultations, high-resolution diagnostics, and priority access to Commons’ “FastPass” network of top physicians.
Whether flagging genetic cancer risk, coronary plaque, or hormonal imbalances, Commons accelerates intervention by unifying testing, triage, and treatment.
Expanded scope. Starting in musculoskeletal health, Commons’ seven LA-area clinics combined noninvasive care and advanced surgical procedures under one roof.
Now, it’s scaling that model across high-impact categories, pairing diagnostics to avoid unnecessary operations and top-tier specialists to perform robotic surgical firsts.
Personalized prevention. As consumers invest in longevity and early detection, co-founder and CEO Nick Aubin says Commons is meeting demand for proactive care.
“Specialty healthcare too often begins after prevention fails… leaving conditions to worsen over time before they receive treatment.”
With platforms like Function and Neko redefining diagnostics, Commons will adopt similar tech to advance a physician-led, time-sensitive alternative to traditional care.
Punchline: In a system built to react, Commons is closing the gap between insight and intervention.
